Form 4: Coherent Director Exercises Options, Sells Shares
Insider Transaction Report
Coherent Corp. Director Joseph J. Corasanti exercised stock options and subsequently sold a portion of his common stock holdings.
Summary
- Joseph J. Corasanti, a Director of Coherent Corp. (COHR), engaged in multiple transactions on November 7, 2025.
- Exercised options to acquire 5,700 shares of common stock at an exercise price of $35.25 per share. These options vested in four equal annual installments starting August 18, 2018.
- Exercised options to acquire 4,020 shares of common stock at an exercise price of $49.9 per share. These options vested in four equal annual installments starting August 28, 2019.
- Sold 9,720 shares of common stock at a weighted average price of $151.2489 per share, with individual sale prices ranging from $151.02 to $151.43.
- Following these transactions, Corasanti directly beneficially owns 94,914 shares of Coherent Corp. common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While a director sold shares, it was preceded by option exercises, indicating a realization of value from long-held equity. The sale itself is a common practice for liquidity and diversification and does not necessarily signal a negative outlook on the company.
Positives
- Director Corasanti realized a significant gain by exercising options at lower prices ($35.25 and $49.9) and selling shares at a much higher price ($151.2489).
- The exercise of options indicates a realization of value from long-held equity.
Negatives
- The sale of 9,720 shares by a director could be interpreted as a reduction in insider exposure, although it is common for executives to sell shares after exercising options for liquidity or diversification.
Future Outlook
NA
Industry Context
This is an insider transaction report, which is specific to the individual and company, not directly related to broader industry trends unless it is part of a larger pattern of insider selling across the sector. Without more context, it is hard to draw industry-wide conclusions.
Stakeholder Impact
- Shareholders may note the director's sale of shares, which could be interpreted in various ways, from routine diversification to a slight reduction in insider alignment. However, the overall impact is likely minimal given the nature of the transaction.
Key Dates
| Date | Description |
|---|---|
| 08/18/2018 | Start of four equal annual installments for vesting of 5,700 options. |
| 08/28/2019 | Start of four equal annual installments for vesting of 4,020 options. |
| 11/07/2025 | Date of option exercises and common stock sale transactions. |
| 08/18/2027 | Expiration date for 5,700 options. |
| 08/28/2028 | Expiration date for 4,020 options. |
| 11/12/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe filing details a routine insider transaction where a director exercised vested stock options and subsequently sold a portion of the acquired shares. This is a common practice for liquidity and portfolio diversification and does not inherently signal a change in the company's fundamental outlook. Without additional information on the company's performance or strategic direction, this transaction alone does not warrant a change from a 'hold' position.
Keywords
Coherent Corp, COHR, Form 4, Insider Trading, Stock Options, Director Transactions, Equity Sales, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.